1.
Two-Year Clinical Outcomes of the PAUL Glaucoma Implant in White Patients With Refractory Glaucoma.
Weber Constance, Hundertmark Sarah, Stasik Isabel, Holz Frank G, Mercieca Karl
J GlaucomaJun 202414 citationsCase Series
This study found the PAUL Glaucoma Implant effectively lowered eye pressure and medication needs over two years in white patients, with a temporary stent preventing early hypotony and allowing further pressure reduction.